A retrospective real world outcomes of semaglutide in patients with overweight and obesity
Latest Information Update: 23 Dec 2022
At a glance
- Drugs Semaglutide (Primary)
- Indications Obesity; Overweight
- Focus Therapeutic Use
Most Recent Events
- 23 Dec 2022 New trial record
- 04 Nov 2022 Results presented at The Obesity Society: ObesityWeek 2022